BIOLASE Tech (BLTI) Sees Q4, FY11 Revs Coming In Below Views
Get Alerts BLTI Hot Sheet
Price: $2.42 +2.54%
Financial Fact:
Engineering and development: 1.72M
Today's EPS Names:
SHIM, KOD, HEWA, More
Financial Fact:
Engineering and development: 1.72M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
BIOLASE Technology, Inc. (NASDAQ: BLTI), announced that, based on a preliminary review of its financial performance for the fourth quarter ended December 31, 2011, the Company expects to report net revenue of approximately $13.1 million. This would represent net revenue growth of 35 percent year over year from $9.7 million in the fourth quarter of 2010. Net revenue for the fiscal year ended December 31, 2011, is expected to total approximately $48.8 million, up 86 percent year over year from $26.2 million in 2010.
The Street sees Q4 revs of $15.7 million and FY12 revs of $51.40 million.
Excluding equipment sales to Henry Schein, Inc. (NASDAQ: HSIC), net revenue for the fourth quarter ended December 31, 2011, is expected to total approximately $13.1 million compared to approximately $7.2 million for the fourth quarter ended December 31, 2010, an increase of approximately $5.9 million, or 82 percent.
The Street sees Q4 revs of $15.7 million and FY12 revs of $51.40 million.
Excluding equipment sales to Henry Schein, Inc. (NASDAQ: HSIC), net revenue for the fourth quarter ended December 31, 2011, is expected to total approximately $13.1 million compared to approximately $7.2 million for the fourth quarter ended December 31, 2010, an increase of approximately $5.9 million, or 82 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
- Ford Motor (F) CFO Lawler to Affirm Full-Year 2024 Operating Guidance
- Carnival Corp. (CCL) tops Q1 expectations as booking volumes 'hit an all-time high'
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!